Angiographic and Optical Coherence Tomographic Results of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration
- 16 July 2007
- journal article
- case report
- Published by Elsevier in Ophthalmology
- Vol. 114 (10), 1868-1875.e4
- https://doi.org/10.1016/j.ophtha.2007.04.030
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Pegaptanib for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2004
- Vascular Endothelial Growth Factor Family and Receptor Expression in Human Choroidal Neovascular MembranesMicrovascular Research, 2002
- Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured fab in complex with antigen 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1999
- Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor Are Present in Epiretinal and Choroidal Neovascular MembranesAmerican Journal of Ophthalmology, 1996
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.Journal of Biological Chemistry, 1992